Article
Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
BMC pediatrics - 4 Feb 2023
Shen Diying, Liu Lixia, Xu Xiaojun, Song Hua, Zhang Jingying, Xu Weiqun, Zhao Fenying, Liang Juan, Liao Chan, Wang Yan, Xia Tian, Wang Chengcheng, Lou Feng, Cao Shanbo, Qin Jiayue, Tang Yongmin
Abstract excerpt
PURPOSE: The 5-year survival rate of children with acute lymphoblastic leukemia (ALL) is 85-90%, with a 10-15% rate of treatment failure. Next-generation sequencing (NGS) identified recurrent mutated genes in ALL that might alter the diagnosis, classification, prognostic stratification, treatment, and response to ALL. Few studies on gene mutations in Chinese pediatric ALL have been identified. Thus, an in-depth...
Topics
Join the communities discussing this publication.
